EP2197897A4 - Peptides à auto-assemblage à base d'appariement d'acides aminés et procédés - Google Patents

Peptides à auto-assemblage à base d'appariement d'acides aminés et procédés

Info

Publication number
EP2197897A4
EP2197897A4 EP08800379A EP08800379A EP2197897A4 EP 2197897 A4 EP2197897 A4 EP 2197897A4 EP 08800379 A EP08800379 A EP 08800379A EP 08800379 A EP08800379 A EP 08800379A EP 2197897 A4 EP2197897 A4 EP 2197897A4
Authority
EP
European Patent Office
Prior art keywords
methods
amino acid
based self
acid matching
assembly peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08800379A
Other languages
German (de)
English (en)
Other versions
EP2197897A1 (fr
Inventor
Pu Chen
Hong Yang
Shane Fung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Waterloo
Original Assignee
University of Waterloo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Waterloo filed Critical University of Waterloo
Publication of EP2197897A1 publication Critical patent/EP2197897A1/fr
Publication of EP2197897A4 publication Critical patent/EP2197897A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M4/00—Electrodes
    • H01M4/86—Inert electrodes with catalytic activity, e.g. for fuel cells
    • H01M4/8605—Porous electrodes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/30—Hydrogen technology
    • Y02E60/50—Fuel cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Electrochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
EP08800379A 2007-08-30 2008-08-29 Peptides à auto-assemblage à base d'appariement d'acides aminés et procédés Withdrawn EP2197897A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93577307P 2007-08-30 2007-08-30
PCT/CA2008/001688 WO2009026729A1 (fr) 2007-08-30 2008-08-29 Peptides à auto-assemblage à base d'appariement d'acides aminés et procédés

Publications (2)

Publication Number Publication Date
EP2197897A1 EP2197897A1 (fr) 2010-06-23
EP2197897A4 true EP2197897A4 (fr) 2012-08-08

Family

ID=40386636

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08800379A Withdrawn EP2197897A4 (fr) 2007-08-30 2008-08-29 Peptides à auto-assemblage à base d'appariement d'acides aminés et procédés

Country Status (4)

Country Link
EP (1) EP2197897A4 (fr)
CN (1) CN101939329A (fr)
CA (1) CA2697951A1 (fr)
WO (1) WO2009026729A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG174857A1 (en) * 2009-03-09 2011-11-28 Menicon Co Ltd Self-assembling peptide and peptide gel with high strength
CN102199195B (zh) * 2011-03-07 2014-04-02 华南理工大学 一类半程电荷匹配两亲性自组装短肽及其用作纳米止血材料及疏水性药物载体
EP3375457B1 (fr) 2011-11-24 2020-06-24 Positec Power Tools (Suzhou) Co., Ltd Conception de séquences peptidiques et leur utilisation pour l'administration d'arnsi induite par des peptides
CN102911258B (zh) * 2012-07-06 2014-07-30 江苏大学 有机小分子调控多肽组装形成二维多肽纳米薄片的方法
EP2698162A1 (fr) 2012-08-15 2014-02-19 Credentis AG Procédé de production d'une composition pour traiter une lésion dentaire
EP3049054B1 (fr) 2013-09-25 2018-04-04 Credentis AG Produit de soins dentaires pour le blanchiment des dents
EP2853256A1 (fr) 2013-09-25 2015-04-01 Credentis AG Produit de soins dentaires pour le blanchiment des dents
CN104725478B (zh) 2013-12-18 2018-12-25 纳肽得有限公司 多肽化合物、多肽化合物与siRNA的组装体及其应用
EP3696536A1 (fr) 2015-04-14 2020-08-19 Illumina, Inc. Procédé de fabrication d'un substrat et procédé d'analyse de biomolécules aptes à générer des émissions de lumière
EP3248590A1 (fr) 2016-05-24 2017-11-29 Credentis AG Produit de soin dentaire personnel pour traitement des caries
EP3248591A1 (fr) 2016-05-24 2017-11-29 Credentis AG Procédé et produit de traitement de caries
CN106749518B (zh) * 2016-11-10 2021-01-01 国家纳米科学中心 一种含有双芘基团的多肽纳米材料及其制备方法和应用
CN106699841B (zh) * 2017-01-05 2020-07-24 北京大学深圳研究生院 一种自组装的多肽纳米棒及其制备方法
CN107033219B (zh) * 2017-04-07 2020-07-28 中国石油大学(华东) 一种自组装肽及其作为dna凝聚试剂的应用
CN108659103A (zh) * 2018-08-30 2018-10-16 安徽工程大学 一种离子互补型自组装肽及其制备方法
CN109364257A (zh) * 2018-10-18 2019-02-22 南开大学 一种动态性及稳定性兼备的多肽杂化高分子纳米药物制备方法
EP3831360A1 (fr) 2019-12-04 2021-06-09 Credentis AG Produit de soin dentaire personnel pour éviter la déminéralisation
CN111040026B (zh) * 2019-12-10 2021-03-05 中山大学附属口腔医院 淀粉样六肽及其广谱抑制细菌和真菌生物膜的应用
CN111840547B (zh) * 2020-06-15 2023-04-28 山西振东泰盛制药有限公司 注射用培美曲塞磁性自组装纳米复合颗粒制备方法
CN111748016B (zh) * 2020-07-03 2023-05-02 四川大学华西医院 一种基于非典型疏水性氨基酸的自组装短肽及其应用
US11154470B1 (en) 2020-07-31 2021-10-26 vVardis AG Anti-inflammatory and senolytic dental care product with tooth whitening characteristics
EP3988509B1 (fr) * 2020-10-21 2025-01-08 Hellma GmbH & Co. KG Fabrication de corps moulés en verre de silice de différentes couleurs allant du gris au noir pour des applications optiques
CN114660160A (zh) * 2020-12-22 2022-06-24 陈璞 确定多肽与siRNA共组装体中最小包载结合比的方法
CN112760349A (zh) * 2021-02-04 2021-05-07 海南华研胶原科技股份有限公司 一种酶解法提取大豆肽的方法
CN113477194A (zh) * 2021-06-21 2021-10-08 江苏大学 一种基于聚合物包覆调控一维自组装纳米材料长度分布的方法
CN116377599A (zh) * 2023-03-09 2023-07-04 国家纳米科学中心 一种筛选pH响应自组装多肽的方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0457314A1 (fr) * 1990-05-18 1991-11-21 Clintec Nutrition Company Composition nutritives contenant des peptides
WO2002068601A2 (fr) * 2001-02-28 2002-09-06 Skubitz Keith M Peptides de petite taille a capacite de modulation de la fonction des membres de la famille des cd66 (ceacam)
WO2004007532A2 (fr) * 2002-07-15 2004-01-22 University Of Leeds Reseaux
WO2006014570A2 (fr) * 2004-07-06 2006-02-09 3D Matrix, Inc. Compositions peptidiques amphiphiles purifiees et utilisations de celles-ci
WO2006081249A2 (fr) * 2005-01-25 2006-08-03 Cell Therapeutics, Inc. Conjugues de proteine biologiquement actives possedant une demi-vie in vivo modifiee

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179784B2 (en) * 2001-07-10 2007-02-20 Massachusetts Institute Of Technology Surfactant peptide nanostructures, and uses thereof
US20050118494A1 (en) * 2003-12-01 2005-06-02 Choi Sung H. Implantable biofuel cell system based on nanostructures
WO2006071895A2 (fr) * 2004-12-28 2006-07-06 Nanomix, Inc. Dispositifs nanoelectroniques pour la detection d'adn et la reconnaissance de sequences polynucleotidiques
WO2006047315A2 (fr) * 2004-10-25 2006-05-04 The Brigham And Women's Hospital, Inc. Administration ciblee de facteurs biologiques au moyen de nanofibres peptidiques a auto-assemblage

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0457314A1 (fr) * 1990-05-18 1991-11-21 Clintec Nutrition Company Composition nutritives contenant des peptides
WO2002068601A2 (fr) * 2001-02-28 2002-09-06 Skubitz Keith M Peptides de petite taille a capacite de modulation de la fonction des membres de la famille des cd66 (ceacam)
WO2004007532A2 (fr) * 2002-07-15 2004-01-22 University Of Leeds Reseaux
WO2006014570A2 (fr) * 2004-07-06 2006-02-09 3D Matrix, Inc. Compositions peptidiques amphiphiles purifiees et utilisations de celles-ci
WO2006081249A2 (fr) * 2005-01-25 2006-08-03 Cell Therapeutics, Inc. Conjugues de proteine biologiquement actives possedant une demi-vie in vivo modifiee

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CARRICK ET AL: "Effect of ionic strength on the self-assembly, morphology and gelation of pH responsive beta-sheet tape-forming peptides", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 63, no. 31, 21 June 2007 (2007-06-21), pages 7457 - 7467, XP022124611, ISSN: 0040-4020, DOI: 10.1016/J.TET.2007.05.036 *
CHEN ET AL: "Self-assembly of ionic-complementary peptides: a physicochemical viewpoint", COLLOIDS AND SURFACES. A, PHYSICACHEMICAL AND ENGINEERING ASPECTS, ELSEVIER, AMSTERDAM, NL, vol. 261, no. 1-3, 1 July 2005 (2005-07-01), pages 3 - 24, XP027802761, ISSN: 0927-7757, [retrieved on 20050701] *
JÖRG GSPONER, URS HABERTHÜR, AMEDEO CAFLISCH: "The role of side-chain interactions in the early steps of aggregation: Molecular dynamics simulation of an amyloid-forming peptide from the yeast prion Sup35", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE OF THE USA, vol. 100, no. 9, 29 April 2003 (2003-04-29), pages 5154 - 5149, XP002678609 *
See also references of WO2009026729A1 *

Also Published As

Publication number Publication date
CN101939329A (zh) 2011-01-05
EP2197897A1 (fr) 2010-06-23
WO2009026729A1 (fr) 2009-03-05
CA2697951A1 (fr) 2009-03-05

Similar Documents

Publication Publication Date Title
EP2197897A4 (fr) Peptides à auto-assemblage à base d'appariement d'acides aminés et procédés
HUS2200045I1 (hu) Szintetikus peptid-amidok
EP2350043A4 (fr) Lipides aminés améliorés et procédés d'administration d'acides nucléiques
HRP20181823T1 (hr) Aminokiselinski lipidi i njihove primjene
EP2249853A4 (fr) Promédicaments peptidiques à base d' esters
EP2132334A4 (fr) Procédés et compositions associés à la détection d'acides nucléiques
EP2170363A4 (fr) Conjugués peptidiques spécifiques d'un tissu et procédés
HRP20130114T1 (xx) Farmaceutski oblik s brzim oslobađanjem sinakalcet hci
EP2037737A4 (fr) Protéines, acides nucléiques encodant celles-ci et leurs procédés d'utilisation associés
IL248025A0 (en) Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
EP2329359A4 (fr) Identification de métadonnées d'application dans un flux de sauvegarde
EP2329402A4 (fr) Identification d'objet dans des images
EP2277890A4 (fr) Peptide capable de prolonger la demi-vie de peptide d'intérêt dans le plasma
EP2043696A4 (fr) Procédés et compositions de ciblage de la protéine gc1qr/p32
EP2157919A4 (fr) Dispositifs et procédés d'administration endoscopique
DK1988163T3 (da) Hla-a*3303-begrænset wt1 peptid og farmaceutisk sammensætning omfattende det samme
EP2203886A4 (fr) Agrégation et délivrance d'informations
EP2234594A4 (fr) Compositions et procédés dermatologiques à base d'extrait de tramètes
EP2210601A4 (fr) Agent antifatigue comprenant une composition d'acides aminés
BRPI0821871A2 (pt) Suspensão farmacêutica oral compreendendo paracetamol e ibuprofeno
EP2061487A4 (fr) Modifications de peptides dérivés de la cuprédoxine et procédés d'utilisation de ceux-ci
EP2076967A4 (fr) Terminal et procédé d'affichage associé
EP2346521A4 (fr) Peptides et procédés d'utilisation
EP1768951A4 (fr) Acides amines non naturels
EP2126076A4 (fr) Protéines dérivées des toiles d' araignées néphilengys cruentata avicularia juruensis et parawixia bistriata

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100330

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: B82B 1/00 20060101ALI20120628BHEP

Ipc: A61K 47/18 20060101ALI20120628BHEP

Ipc: A61K 47/42 20060101ALI20120628BHEP

Ipc: C07K 5/113 20060101ALI20120628BHEP

Ipc: C11D 1/88 20060101ALI20120628BHEP

Ipc: C07K 1/00 20060101ALI20120628BHEP

Ipc: G01N 33/66 20060101ALI20120628BHEP

Ipc: A61P 35/00 20060101ALI20120628BHEP

Ipc: H01M 8/22 20060101ALI20120628BHEP

Ipc: G01N 33/569 20060101ALI20120628BHEP

Ipc: C07K 7/06 20060101AFI20120628BHEP

Ipc: C07K 5/06 20060101ALI20120628BHEP

Ipc: C07K 5/072 20060101ALI20120628BHEP

Ipc: A61K 45/08 20060101ALI20120628BHEP

Ipc: A61K 38/02 20060101ALI20120628BHEP

Ipc: G01N 33/50 20060101ALI20120628BHEP

Ipc: G01N 33/68 20060101ALI20120628BHEP

Ipc: C07K 5/10 20060101ALI20120628BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20120705

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130205